Hot penny stocks... don't get burned
   

News for Optimer Pharmaceuticals, Inc (OPTR)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Optimer Pharmaceuticals Inc.  (OPTR) 
|
$ 5.32      1.07 (+25.18%) Volume: 58.87 k 10:56 AM EDT Oct 13, 2008
Wed, Sep 10, 2008
8:02 AM Optimer Pharmaceuticals to Present at Two Upcoming Investor Conferences - Business Wire
Tue, Sep 02, 2008
8:33 AM Optimer Pharmaceuticals Completes Enrollment in Second Prulifloxacin Phase 3 Clinical Trial - Business Wire
Thu, Aug 28, 2008
8:01 AM Optimer Pharmaceuticals to Present at BioCentury NewsMakers Conference - Business Wire
Wed, Aug 06, 2008
8:05 AM Optimer Pharmaceuticals Reports Second Quarter 2008 Financial Results - Business Wire
Wed, Jul 30, 2008
8:04 AM Optimer Pharmaceuticals to Present at August 2008 Investor Conferences - Business Wire
Mon, Jul 28, 2008
5:32 PM Optimer Pharmaceuticals Completes $14.8 Million Registered Direct Offering - Business Wire
Wed, Jul 23, 2008
8:05 AM Optimer Pharmaceuticals Completes Enrollment in OPT-80 Phase 3 Clinical Trial in Patients with Clostridium difficile Infection - Business Wire
Mon, Jul 21, 2008
8:09 AM Optimer Pharmaceuticals to Raise $12.2 Million in Registered Direct Offering - Business Wire
Thu, Jul 17, 2008
2:23 PM Optimer Pharmaceuticals Announces Change to Board of Directors - Business Wire
Wed, Jul 16, 2008
3:37 AM Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin Phase 3 Study - Business Wire
Thu, Jun 26, 2008
6:30 PM Optimer Reports Additional Data on Investigational Compound OPT-80 at Anaerobe 2008 Congress - Business Wire
Tue, Jun 17, 2008
9:50 AM Optimer Pharmaceuticals to Present at Two Upcoming Investor Conferences - Business Wire
Wed, Jun 11, 2008
8:00 AM Optimer to Present Additional Data from OPT-80 Phase 2A Study for Clostridium difficile Infection at Anaerobe 2008 Congress - Business Wire
Tue, Jun 03, 2008
8:21 AM Optimer Pharmaceuticals to Present at Needham Biotechnology & Medical Technology Conference - Business Wire
Tue, May 27, 2008
8:16 AM Optimer Pharmaceuticals Receives Polymorph Patent for Lead Product Candidate OPT-80 - Business Wire
Wed, May 07, 2008
8:06 AM Optimer Pharmaceuticals Reports First Quarter 2008 Financial Results - Business Wire
Tue, May 06, 2008
8:18 AM Optimer Pharmaceuticals to Present at Upcoming Investor Conferences - Business Wire
Mon, Apr 21, 2008
8:17 AM Clostridium difficile Infection 'Epidemic' Leads to Calls for Emerging Next-Generation Therapies - Business Wire
Tue, Apr 15, 2008
8:24 AM Optimer Pharmaceuticals Sponsors ECCMID Symposium on Clostridium Difficile-Associated Disease: Current Treatments and Challenges - Business Wire
Tue, Apr 08, 2008
8:30 AM Optimer Pharmaceuticals Receives Notice of Allowance for OPT-80 Patent Application - Business Wire
Wed, Apr 02, 2008
8:19 AM Optimer Pharmaceuticals Announces Peer-Reviewed Publication of OPT-80 Phase 1 Clinical Results for the Treatment of Clostridium Difficile Infection - Business Wire
Wed, Mar 26, 2008
8:17 AM Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results - Business Wire
Wed, Mar 14, 2007
8:00 AM Optimer Pharmaceuticals Advances Difimicin Into Phase 3 Clinical Trial - GlobeNewswire
Tue, Feb 27, 2007
8:00 AM Optimer Pharmaceuticals Regains North American Rights to Difimicin (Par-101/Opt-80) - GlobeNewswire
Wed, Feb 21, 2007
8:00 AM Optimer Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option by Underwriters - GlobeNewswire
  Page 1 of 2   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for OPTR stock. Download OPTR report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download OPTR report
  
Example preview: Research report for Optimer Pharmaceuticals, Inc (OPTR) Research report for Optimer Pharmaceuticals, Inc (OPTR) Research report for Optimer Pharmaceuticals, Inc (OPTR) Research report for Optimer Pharmaceuticals, Inc (OPTR)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Optimer Pharmaceuticals, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.